Skip to main content
Top
Published in: International Urology and Nephrology 8/2014

01-08-2014 | Urology - Original Paper

The application of tissue-engineered preputial matrix and fibrin sealant for urethral reconstruction in rabbit model

Authors: Abdol-Mohammad Kajbafzadeh, Shabnam Sabetkish, Ali Tourchi, Naser Amirizadeh, Kourosh Afshar, Hassan Abolghasemi, Azadeh Elmi, Saman Shafaat Talab, Peyman Eshghi, Mohammad Javad Mohseni

Published in: International Urology and Nephrology | Issue 8/2014

Login to get access

Abstract

Background

To introduce the role of fibrin sealant and preputial acellular matrix (PAM) as a new source of inert collagen matrix for urethral reconstruction.

Methods

A ventral urethral segmental defect was created in 24 male rabbits divided into four groups. In group 1 (G1), urethrotomy was closed in layers. In group 2 (G2), closure was followed by applying fibrin sealant. In groups 3 (G3) and 4 (G4), urethroplasty was performed with a patch graft of PAM, and in G4, fibrin sealant was also applied. Serial urethrography was performed before and after the operation. Then, the animals were euthanized, and their urethra was excised 1, 3, and 9 months postoperatively for further electron microscopic examination, terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) technique, and immunohistochemical (IHC) staining with CD34, CD31, desmin, SMA, and α-actin.

Results

In G1 and G2, the fistula repair failed in all the time points. In G3 and G4, serial urethrography confirmed the maintenance of a wide urethral caliber without signs of strictures or extravasations. Satisfactory vascularity was observed in G3 and G4 during the whole study, which was more significant in G4 after 9 months of follow-up. The presence of a complete transitional cell layer was confirmed over the graft in G3 and G4 in all time points. IHC staining confirmed the effectiveness of fistula repair in G3 and G4, 3 months postoperatively.

Conclusion

This rabbit model showed that PAM combined with fibrin sealant may herald a reliable option for repairing segmental urethral defects.
Literature
1.
go back to reference Aulagne M, Harper L, de Napoli-Cocci S, Bondonny J, Dobremez E (2010) Long-term outcome of severe hypospadias. J Pediatr Urol 6(5):469–472PubMedCrossRef Aulagne M, Harper L, de Napoli-Cocci S, Bondonny J, Dobremez E (2010) Long-term outcome of severe hypospadias. J Pediatr Urol 6(5):469–472PubMedCrossRef
2.
go back to reference Snodgrass W, Macedo A, Hoebeke P, Mouriquand PD (2011) Hypospadias dilemmas: a round table. J Pediatr Urol 7(2):145PubMedCrossRef Snodgrass W, Macedo A, Hoebeke P, Mouriquand PD (2011) Hypospadias dilemmas: a round table. J Pediatr Urol 7(2):145PubMedCrossRef
3.
go back to reference Raya-Rivera A, Esquiliano DR, Yoo JJ, Lopez-Bayghen E, Soker S, Atala A (2011) Tissue-engineered autologous urethras for patients who need reconstruction: an observational study. Lancet 377(9772):1175–1182PubMedCentralPubMedCrossRef Raya-Rivera A, Esquiliano DR, Yoo JJ, Lopez-Bayghen E, Soker S, Atala A (2011) Tissue-engineered autologous urethras for patients who need reconstruction: an observational study. Lancet 377(9772):1175–1182PubMedCentralPubMedCrossRef
4.
5.
go back to reference Palminteri E, Berdondini E, Colombo F, Austoni E (2007) Small intestinal submucosa (SIS) graft urethroplasty: short-term results. Eur Urol 51(6):1695–1701PubMedCrossRef Palminteri E, Berdondini E, Colombo F, Austoni E (2007) Small intestinal submucosa (SIS) graft urethroplasty: short-term results. Eur Urol 51(6):1695–1701PubMedCrossRef
7.
go back to reference Evans LA, Morey AF (2006) Current applications of fibrin sealant in urologic surgery. Int Braz J Urol 32(2):131–141PubMedCrossRef Evans LA, Morey AF (2006) Current applications of fibrin sealant in urologic surgery. Int Braz J Urol 32(2):131–141PubMedCrossRef
8.
go back to reference Kajbafzadeh A-M, Abolghasemi H, Eshghi P, Alizadeh F, Elmi A, Shafaattalab S et al (2011) Single-donor fibrin sealant for repair of urethrocutaneous fistulae following multiple hypospadias and epispadias repairs. J Pediatr Urol 7(4):422–427PubMedCrossRef Kajbafzadeh A-M, Abolghasemi H, Eshghi P, Alizadeh F, Elmi A, Shafaattalab S et al (2011) Single-donor fibrin sealant for repair of urethrocutaneous fistulae following multiple hypospadias and epispadias repairs. J Pediatr Urol 7(4):422–427PubMedCrossRef
9.
go back to reference Gopal SC, Gangopadhyay AN, Mohan TV, Upadhyaya VD, Pandey A, Upadhyaya A et al (2008) Use of fibrin glue in preventing urethrocutaneous fistula after hypospadias repair. J Pediatr Surg 43(10):1869–1872PubMedCrossRef Gopal SC, Gangopadhyay AN, Mohan TV, Upadhyaya VD, Pandey A, Upadhyaya A et al (2008) Use of fibrin glue in preventing urethrocutaneous fistula after hypospadias repair. J Pediatr Surg 43(10):1869–1872PubMedCrossRef
10.
go back to reference Oosterlinck W, Cheng H, Hoebeke P, Verbeeck R (1993) Watertight sutures with fibrin glue: an experimental study. Eur Urol 23(4):481–484PubMed Oosterlinck W, Cheng H, Hoebeke P, Verbeeck R (1993) Watertight sutures with fibrin glue: an experimental study. Eur Urol 23(4):481–484PubMed
11.
12.
go back to reference Baskin LS, Ebbers MB (2006) Hypospadias: anatomy, etiology, and technique. J Pediatr Surg 41(3):463–472PubMedCrossRef Baskin LS, Ebbers MB (2006) Hypospadias: anatomy, etiology, and technique. J Pediatr Surg 41(3):463–472PubMedCrossRef
13.
go back to reference Manzoni G, Bracka A, Palminteri E, Marrocco G (2004) Hypospadias surgery: when, what and by whom? BJU Int 94(8):1188–1195PubMedCrossRef Manzoni G, Bracka A, Palminteri E, Marrocco G (2004) Hypospadias surgery: when, what and by whom? BJU Int 94(8):1188–1195PubMedCrossRef
15.
go back to reference Sievert K-D, Amend B, Stenzl A (2007) Tissue engineering for the lower urinary tract: a review of a state of the art approach. Eur Urol 52(6):1580–1589PubMedCrossRef Sievert K-D, Amend B, Stenzl A (2007) Tissue engineering for the lower urinary tract: a review of a state of the art approach. Eur Urol 52(6):1580–1589PubMedCrossRef
16.
go back to reference Mantovani F, Trinchieri A, Mangiarotti B, Nicola M, Castelnuovo C, Confalonieri S et al (2002) Reconstructive urology. Arch Ital Urol Androl 74:127–128PubMed Mantovani F, Trinchieri A, Mangiarotti B, Nicola M, Castelnuovo C, Confalonieri S et al (2002) Reconstructive urology. Arch Ital Urol Androl 74:127–128PubMed
17.
go back to reference Badylak SF, Lantz GC, Coffey A, Geddes LA (1989) Small intestinal submucosa as a large diameter vascular graft in the dog. J Surg Res 47(1):74–80PubMedCrossRef Badylak SF, Lantz GC, Coffey A, Geddes LA (1989) Small intestinal submucosa as a large diameter vascular graft in the dog. J Surg Res 47(1):74–80PubMedCrossRef
18.
go back to reference Sandusky G Jr, Badylak S, Morff R, Johnson W, Lantz G (1992) Histologic findings after in vivo placement of small intestine submucosal vascular grafts and saphenous vein grafts in the carotid artery in dogs. Am J Pathol 140(2):317PubMedCentralPubMed Sandusky G Jr, Badylak S, Morff R, Johnson W, Lantz G (1992) Histologic findings after in vivo placement of small intestine submucosal vascular grafts and saphenous vein grafts in the carotid artery in dogs. Am J Pathol 140(2):317PubMedCentralPubMed
19.
go back to reference De Filippo RE, Yoo JJ, Atala A (2002) Urethral replacement using cell seeded tubularized collagen matrices. J Urol 168(4):1789–1793PubMedCrossRef De Filippo RE, Yoo JJ, Atala A (2002) Urethral replacement using cell seeded tubularized collagen matrices. J Urol 168(4):1789–1793PubMedCrossRef
20.
go back to reference Fossum M, Svensson J, Kratz G, Nordenskjöld A (2007) Autologous in vitro cultured urothelium in hypospadias repair. J Pediatr Urol 3(1):10–18PubMedCrossRef Fossum M, Svensson J, Kratz G, Nordenskjöld A (2007) Autologous in vitro cultured urothelium in hypospadias repair. J Pediatr Urol 3(1):10–18PubMedCrossRef
21.
go back to reference Ambriz-González G, Velázquez-Ramírez GA, García-González JL, de León-Gómez JMG, Muciño-Hernández MI, González-Ojeda A et al (2007) Use of fibrin sealant in hypospadias surgical repair reduces the frequency of postoperative complications. Urol Int 78(1):37–41PubMedCrossRef Ambriz-González G, Velázquez-Ramírez GA, García-González JL, de León-Gómez JMG, Muciño-Hernández MI, González-Ojeda A et al (2007) Use of fibrin sealant in hypospadias surgical repair reduces the frequency of postoperative complications. Urol Int 78(1):37–41PubMedCrossRef
22.
go back to reference Hick EJ, Morey AF (2004) Initial experience with fibrin sealant in pendulous urethral reconstruction. Is early catheter removal possible? J Urol 171(4):1547–1549PubMedCrossRef Hick EJ, Morey AF (2004) Initial experience with fibrin sealant in pendulous urethral reconstruction. Is early catheter removal possible? J Urol 171(4):1547–1549PubMedCrossRef
Metadata
Title
The application of tissue-engineered preputial matrix and fibrin sealant for urethral reconstruction in rabbit model
Authors
Abdol-Mohammad Kajbafzadeh
Shabnam Sabetkish
Ali Tourchi
Naser Amirizadeh
Kourosh Afshar
Hassan Abolghasemi
Azadeh Elmi
Saman Shafaat Talab
Peyman Eshghi
Mohammad Javad Mohseni
Publication date
01-08-2014
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 8/2014
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-014-0684-3

Other articles of this Issue 8/2014

International Urology and Nephrology 8/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.